Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum iShares Trust - iShares Biotechnology ETF IBB

The fund seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on The NASDAQ Stock Market (NASDAQ). The fund seeks to track the investment results of the NASDAQ Biotechnology Index (the Underlying Index), which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as... see more

Bullboard (NDAQ:IBB)

View:
User Avatar Image
(90)
•••
  • StockHorizX
Post by StockHorizon Nov 25, 2024 10:44am

GenAI Revolution in Biotech: $MYNZ and IBB

As IBB gains traction, $MYNZ stands out with its cutting-edge diagnostics focus. GenAI’s role in enhancing research and patient outcomes is a game-changer, boosting the biotech narrative. Both the ...more  
User Avatar Image
(17)
•••
  • TurboOrbit401X
Post by TurboOrbit401on Nov 25, 2024 10:29am

Biotech Innovation: $MYNZ and IBB

$MYNZ is making strides in diagnostics, aligning with the biotech sector’s renewed energy. The IBB index reflects this momentum, driven by innovations like GenAI, which holds transformative potential ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities